Lack of expression of the recombination activating genes RAG-1 and RAF- 2 in cutaneous T-cell lymphoma: Pathogenic implications

Clinical and Experimental Dermatology

Volumn 22, Issue 5, 1997, Pages 230-233

  Dobbeling U ^a   Dummer, R ^a   Hess Schmid, M ^a   Burg, G ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEZARY SYNDROME; SKIN LYMPHOMA; T CELL LYMPHOMA;

AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION; GENES, RAG-1; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; SKIN NEOPLASMS;

EID: 0031431417     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1997.tb01074.x     Document Type: Article

References (26)

1. Burg G, Dummer R, Dommann S et al. Pathology of cutaneous T-cell lymphoma. Hematol/Oncol Clinics N Am 1995; 9: 961-95.
2. Dummer R, Dommann SNW, Hassam S et al. 1995 Diagnostik und Pathogenese kutaner Lymphome. In: Macher E, Kolde G, Bröcker EB, eds. Jahrbuch der Dermatologie. Zülpich: Biermann Verlag, 1995; 151-64.
3. Kaltoft K, Holm-Hansen B, Thestrup-Pedersen K. Cytogenetic findings in cell lines from cutaneous T-cell lymphoma. Dermatologic Clinics 1994; 12: 295-304.
4. Zhang J, Chang C-C, Lombardi L, Dalla-Favera R. Rearranged NFκB2 gene in the HUT 78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. Oncogene 1994; 9: 1931-7.
5. Fracchiolla NS, Lombardi L, Salina M et al. Structural alterations of the NF-kB transcription factor lyt-10 in lymphoid malignancies. Oncogene 1993; 8: 2839-45.
6. Thakur S, Lin H-C, Tseng W-T et al. Rearrangement and altered expression of the NFκB-2 gene in human cutaneous T-lymphoma cells. Oncogene 1994; 9: 2335-44.
7. Tycko B, Reynolds TC, Smith SD, Sklar J. Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T-cell leukemia. J Exp Med 1989; 169: 369-77.
8. Aplan PDL, Ginsberg AM, Cossman J et al. Disruption of the human SCL locus by illegitimate V (D) J reeombinase activity. Science 1990; 250: 1426-9.
9. Gu Y, Cimino G, Alder H et al. The (4; 11) (q21; q23) chromosome translocation in acute leukemias involve the V (D) J recombinase. Proc Natl Acad Sci USA 1992; 89: 10464-8.
10. Negrini M, Felix C-A, Martin C et al. Potential topoisomerase II DNA-binding sites at the breakpoints of a t (9; 11) chromosome translocation in acute myeloid leukemia. Cancer Res 1993; 53: 4489-92.
11. Lipkowitz S, Garry VF, Kirsch IR. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies. Proc Natl Acad Sci USA 1992; 89: 5301-5305.
12. Schatz DG, Oettinger MA, Baltimore D. The V (D) J recombination activating gene. RAG-1 Cell 1989; 59: 1035-48.
13. Oettinger MA, Schatz DG, Gorka C, Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V (D) J recombination. Sci 1990; 248: 1517-23.
14. Mombaerts P, Iacomini J, Johnson RS et al. Rag-1 deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869-77.
15. Shinkai Y, Rathbun G, Lam KP et al. Rag-2 deficient mice lack mature lymphocytes owing to inability to initiate V (D) J rearrangement. Cell 1992; 68: 855-67.
16. Gay D, Saunders T, Camper S, Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 1993; 177: 999-1008.
17. Tiegs SL, Russell DM, Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993; 77: 1009-1020.
18. Borgulya P, Kishi H, Uematsu Y, von Bochmer H. Exclusion and inclusion of a and b T cell receptor alleles. Cell 1992; 69: 529-37.
19. Kaltoft K, Bisballe S, Rasmussen HF et al. A continuous T-cell line from a patient with Sézary syndrome. Arch Dermatol Res 1987; 279: 293-8.
20. Kerl K, Sterry W et al. Classification and staging of cutaneous T cell lymphoma (CTCL). In: Burg G, ed. Recommendations for Staging and Therapy of Cutaneous Lymphomas. Irsee: EORTC/ BMFT Cutaneous Lymphoma Project Group, 1987; 1-11.
21. Glisin V, Crkvenjakov R, Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochem 1974; 13: 2633-7.
22. Döbbeling U, Böni R, Häffner A et al. A simple method to isolate RXA and DXA simultaneously from biopsy material. BioTechniques 1997; 22: 88-90.
23. Potoczna N, Boehnke WH, Nestle FO et al. T cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. J Cutan Pathol 1996; 23: 298-305.
24. Alt FW, Rathbun G, Oltz F. et al. Function and control of recombination-activity. Ann N Y Acad Sci 1992; 651: 277-94.
25. Migliazza A, Lombardi L, Rocchi et al. Heterogeneous chromosomal aberrations generate 3′ truncations of the NFκB2/lyt-10 gene in lymphoid malignancies. Blood 1994; 84: 3850-60.
26. Chang C-C, Zhang J, Lombardi L et al. Rearranged NFκB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol Cell Biol 1995; 15: 5180-7.